Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Jul 16, 2019 9:59am
205 Views
Post# 29924423

Taimed/ THERF

Taimed/ THERFI am confident that things will come back to the reality of value here, and as JFM pointed out, a lot of catalysts coming soon to bring value here.....

But, another point adding to frustration for shareholders in a short term perspective is that TAIMED since more than a month shows a stability and confident in share price moving up........

Not TH........and thats questionning. Because a lot said here that TH/THERF was undervalued versus TAIMED.

Th is being solidly bashed right now..........

Fingers crossed that European approval, FDA's decision for phase 3 (in nash), and Grinspoon study, NASDAQ, and sales for TROGARZO trends continues......and........fingers crossed that all those news come in soon to put light on TH/THERF.....

Because if this company waits another year to deliver, we may face the next wall named ECONOMIC DEPRESSION, and even with goods news, how will TH rock in a bear market ?
When it does not deliver in a BULLISH one ?

FTV.


Bullboard Posts